CONSIDERATIONS TO KNOW ABOUT LAS17

), helps to clarify why KIF15 is able to facilitate resistance to Eg5 inhibitors in vivo. MT gliding driven by both of those mitotic motors was arrested only if they had been independently inhibited, lending assist into the proposal that a mixture drug therapy focusing on these motors could be a workable strategy for overcoming chemotherapeutic res